Although no relevant preclinical studies have confirmed the effect of CAFs on the proximity of CD4+ Treg to tumor cells in locally advanced NSCLC, our study provided a new direction for targeting CAFs to improve the immunosuppressive microenvironment. Here, CD4 is linked to neoplasm.